• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用基于CT的肾脏体积和肾周脂肪测量对慢性肾脏病进行机会性检测。

Opportunistic Detection of Chronic Kidney Disease Using CT-Based Measurements of Kidney Volume and Perirenal Fat.

作者信息

Białek Piotr, Żuberek Michał, Dobek Adam, Falenta Krzysztof, Kurnatowska Ilona, Stefańczyk Ludomir

机构信息

1st Department of Radiology and Diagnostic Imaging, Medical University of Lodz, Kopcinskiego 22 Street, 90-153 Lodz, Poland.

Department of Internal Diseases and Transplant Nephrology, Medical University of Lodz, Kopcinskiego 22 Street, 90-153 Lodz, Poland.

出版信息

J Clin Med. 2025 Aug 20;14(16):5888. doi: 10.3390/jcm14165888.

DOI:10.3390/jcm14165888
PMID:40869714
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12387138/
Abstract

Chronic kidney disease (CKD) is a prevalent condition with many cases remaining undiagnosed, although early detection is essential. Adipose tissue distribution-particularly perirenal fat thickness (PrFT)-has recently been linked to renal pathophysiology. This study assessed the association between CT-derived parameters of fat distribution and kidney morphology with CKD. This retrospective study included 237 patients (117 subjects, 120 controls) who underwent abdominal CT and had serum creatinine data. The dataset was randomly split (70% training, 30% test) to develop and evaluate a logistic regression model. CKD was defined as estimated Glomerular Filtration Rate (eGFR) < 60 mL/min/1.73 m. PrFT was measured as the distance from the posterior renal capsule to the posterior abdominal wall; renal hilum fat was segmented using a -195 to -45 HU range. Additional parameters (measured using automated segmentation tools) included kidney volume (KV), visceral/subcutaneous fat areas, skeletal muscle area and attenuation, and liver attenuation. Bilateral measurements were averaged. KV (OR = 0.249, 95% CI: 0.146-0.422, < 0.001) and PrFT (2nd tercile: OR = 7.720, 95% CI: 2.860-20.839; 3rd tercile: OR = 16.892, 95% CI: 5.727-49.822; both < 0.001) were identified as independent predictors of CKD. These variables were used to construct a simplified model, which demonstrated moderate clinical applicability (AUC = 0.894) when evaluated on the test subset. KV and PrFT emerged as independent predictors of CKD, forming the basis of a simplified model with potential for opportunistic clinical application. This approach may facilitate earlier detection of CKD in patients undergoing CT imaging for unrelated clinical reasons. These imaging parameters are not intended to replace serum creatinine or eGFR but may serve as complementary predictors in specific clinical contexts.

摘要

慢性肾脏病(CKD)是一种常见疾病,许多病例仍未被诊断出来,尽管早期检测至关重要。脂肪组织分布——尤其是肾周脂肪厚度(PrFT)——最近已与肾脏病理生理学联系起来。本研究评估了CT衍生的脂肪分布参数和肾脏形态与CKD之间的关联。这项回顾性研究纳入了237例接受腹部CT检查并拥有血清肌酐数据的患者(117例受试者,120例对照)。数据集被随机拆分(70%用于训练,30%用于测试)以开发和评估逻辑回归模型。CKD被定义为估计肾小球滤过率(eGFR)<60 mL/min/1.73 m²。PrFT测量为从肾后包膜到后腹壁的距离;肾门脂肪使用-195至-45 HU范围进行分割。其他参数(使用自动分割工具测量)包括肾脏体积(KV)、内脏/皮下脂肪面积、骨骼肌面积和衰减以及肝脏衰减。双侧测量值取平均值。KV(OR = 0.249,95% CI:0.146 - 0.422,P < 0.001)和PrFT(第二三分位数:OR = 7.720,95% CI:2.860 - 20.839;第三三分位数:OR = 16.892,95% CI:5.727 - 49.822;两者P < 0.001)被确定为CKD的独立预测因素。这些变量被用于构建一个简化模型,该模型在测试子集中评估时显示出中等的临床适用性(AUC = 0.894)。KV和PrFT成为CKD独立预测因素,构成了一个具有机会性临床应用潜力的简化模型的基础。这种方法可能有助于在因无关临床原因接受CT成像的患者中更早地检测出CKD。这些成像参数并非旨在替代血清肌酐或eGFR,但在特定临床情况下可作为补充预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa93/12387138/7269ac9f06bd/jcm-14-05888-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa93/12387138/b5f55dd32b14/jcm-14-05888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa93/12387138/87dfaf8ffd1e/jcm-14-05888-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa93/12387138/7eb7d51048eb/jcm-14-05888-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa93/12387138/f9f557853181/jcm-14-05888-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa93/12387138/24144d390d2a/jcm-14-05888-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa93/12387138/7269ac9f06bd/jcm-14-05888-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa93/12387138/b5f55dd32b14/jcm-14-05888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa93/12387138/87dfaf8ffd1e/jcm-14-05888-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa93/12387138/7eb7d51048eb/jcm-14-05888-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa93/12387138/f9f557853181/jcm-14-05888-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa93/12387138/24144d390d2a/jcm-14-05888-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa93/12387138/7269ac9f06bd/jcm-14-05888-g006.jpg

相似文献

1
Opportunistic Detection of Chronic Kidney Disease Using CT-Based Measurements of Kidney Volume and Perirenal Fat.利用基于CT的肾脏体积和肾周脂肪测量对慢性肾脏病进行机会性检测。
J Clin Med. 2025 Aug 20;14(16):5888. doi: 10.3390/jcm14165888.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂用于患有早期(1至3期)非糖尿病慢性肾病的成人。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007751. doi: 10.1002/14651858.CD007751.pub2.
4
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
5
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
6
Perirenal fat thickness may be a significant predictor of prognosis and postoperative renal function in renal cancer surgery patients.肾周脂肪厚度可能是肾癌手术患者预后及术后肾功能的重要预测指标。
Sci Rep. 2025 Sep 2;15(1):32341. doi: 10.1038/s41598-025-17865-7.
7
Antioxidants for chronic kidney disease.用于慢性肾病的抗氧化剂。
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD008176. doi: 10.1002/14651858.CD008176.pub2.
8
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
9
Oral adsorbents for preventing or delaying the progression of chronic kidney disease.用于预防或延缓慢性肾脏病进展的口服吸附剂。
Cochrane Database Syst Rev. 2014 Oct 15;2014(10):CD007861. doi: 10.1002/14651858.CD007861.pub2.
10
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在患有早期(1 至 3 期)非糖尿病慢性肾脏病的成人中的应用。
Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3.

本文引用的文献

1
Perirenal Fat and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.肾周脂肪与慢性肾脏病:一项系统评价与Meta分析
Kidney Blood Press Res. 2025;50(1):240-248. doi: 10.1159/000543989. Epub 2025 Mar 7.
2
The ratio of perirenal fat thickness to renal parenchymal thickness, a novel indicator of fat accumulation associated with kidney stones.肾周脂肪厚度与肾实质厚度之比,一种与肾结石相关的脂肪堆积新指标。
Lipids Health Dis. 2025 Mar 7;24(1):86. doi: 10.1186/s12944-025-02497-7.
3
Body composition analysis using CT at three aspects of the lumbar third vertebra and its impact on the diagnosis of sarcopenia.
使用CT对第三腰椎三个层面进行身体成分分析及其对肌少症诊断的影响。
World J Surg Oncol. 2025 Feb 26;23(1):64. doi: 10.1186/s12957-024-03634-9.
4
Ultrasound measurement of perirenal adipose tissue indicates cardiovascular disease, but standardisation is needed: A systematic review.肾周脂肪组织的超声测量提示心血管疾病,但仍需标准化:一项系统评价
Australas J Ultrasound Med. 2024 Oct 20;28(1):e12407. doi: 10.1002/ajum.12407. eCollection 2025 Feb.
5
Usefulness of Radiomics and Kidney Volume Based on Non-Enhanced Computed Tomography in Chronic Kidney Disease: Initial Report.基于非增强计算机断层扫描的影像组学和肾脏体积在慢性肾脏病中的应用价值:初步报告
Kidney Blood Press Res. 2025;50(1):161-170. doi: 10.1159/000543305. Epub 2025 Jan 21.
6
Chronic Kidney Disease Progression-A Challenge.慢性肾脏病进展——一项挑战
Biomedicines. 2024 Sep 27;12(10):2203. doi: 10.3390/biomedicines12102203.
7
Associations of MRI-derived kidney volume, kidney function, body composition and physical performance in ≈38 000 UK Biobank participants: a population-based observational study.约38000名英国生物银行参与者的MRI衍生肾体积、肾功能、身体成分与身体机能的关联:一项基于人群的观察性研究。
Clin Kidney J. 2024 Mar 15;17(4):sfae068. doi: 10.1093/ckj/sfae068. eCollection 2024 Apr.
8
Chronic kidney disease and the global public health agenda: an international consensus.慢性肾脏病与全球公共卫生议程:国际共识。
Nat Rev Nephrol. 2024 Jul;20(7):473-485. doi: 10.1038/s41581-024-00820-6. Epub 2024 Apr 3.
9
Longitudinal changes in renal volumes evaluated by automated three-dimensional volumetric computed tomography of the whole kidney: The association with the renal function and disease progression.采用全自动三维容积 CT 对整个肾脏进行体积评估的肾脏体积的纵向变化:与肾功能和疾病进展的关系。
Eur J Radiol. 2024 Jan;170:111245. doi: 10.1016/j.ejrad.2023.111245. Epub 2023 Nov 29.
10
TotalSegmentator: Robust Segmentation of 104 Anatomic Structures in CT Images.全段分割器:CT图像中104种解剖结构的稳健分割
Radiol Artif Intell. 2023 Jul 5;5(5):e230024. doi: 10.1148/ryai.230024. eCollection 2023 Sep.